Answers are grounded in this paper and cite their sources.
Objective The objective of this study was to determine if the level of Fusobacterium -reactive antibodies, as measured by antibody titer in gingival crevicular fluid and on the basis of frequency among individuals within disease severity groups, are associated with periodontal disease. Methods Study participants (N = 74) were assigned to disease severity groups of healthy, mild, moderate, or severe based on the degree of clinical attachment loss. Gingival crevicular fluid was collected from each participant and levels of antibodies reactive against three Fusobacterium nucleatum antigens were measured by ELISA. Results Fusobacterium -reactive IgG levels were positively correlated with periodontal disease across the disease severity groups. However, among participants with moderate or severe periodontitis, 50-55% had detectable antigen-reactive GCF IgG, depending on the antigen examined. Fusobacterium relative abundance, measured by next- generation sequencing of 16S ribosomal RNA genes, did not differ significantly as a function of disease status but was negatively associated with FNP972-reactive GCF IgG titers (p=0.003). Conclusions Periodontitis is associated with heterogeneous antibody responses and microbiome profiles. Patients with clinically equivalent disease severity can exhibit distinct immune and microbial profiles.
No takes yet. Share an insight, caveat, or question.
Cook et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: